Tissue Determinants of Human NK Cell Development, Function, and Residence. by Dogra, Pranay et al.
UCSF
UC San Francisco Previously Published Works
Title
Tissue Determinants of Human NK Cell Development, Function, and Residence.
Permalink
https://escholarship.org/uc/item/6xt868g0
Journal
Cell, 180(4)
ISSN
0092-8674
Authors
Dogra, Pranay
Rancan, Chiara
Ma, Wenji
et al.
Publication Date
2020-02-12
DOI
10.1016/j.cell.2020.01.022
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Resource
Tissue Determinants of Human NK Cell
Development, Function, and ResidenceGraphical AbstractHighlightsd High-resolution map of human NK cells shows tissue-driven
distribution across ages
d Differentiated NK cells predominate in blood, bone marrow,
spleen, and lungs
d Tissue-resident NK cells exhibit specific adaptations in
mucosal and lymphoid sites
d Lymph nodes and intestines are reservoirs for precursor and
immature NK cellsDogra et al., 2020, Cell 180, 1–15
February 20, 2020 ª 2020 Elsevier Inc.
https://doi.org/10.1016/j.cell.2020.01.022Authors
Pranay Dogra, Chiara Rancan,
Wenji Ma, ..., Lawrence Fong,
Lewis L. Lanier, Donna L. Farber
Correspondence
df2396@cumc.columbia.edu
In Brief
A study of the distribution and function of
natural killer cells across various human
tissues reveals anatomic control of their
development as well as populations that
mediate immunosurveillance
systemically.
Please cite this article in press as: Dogra et al., Tissue Determinants of Human NK Cell Development, Function, and Residence, Cell (2020),
https://doi.org/10.1016/j.cell.2020.01.022ResourceTissue Determinants of Human NK
Cell Development, Function, and Residence
Pranay Dogra,1,2 Chiara Rancan,3 Wenji Ma,4 Marta Toth,5 Takashi Senda,1,6 Dustin J. Carpenter,1,6 Masaru Kubota,1,6
Rei Matsumoto,1,6 Puspa Thapa,1,2 Peter A. Szabo,1,2 Maya Meimei Li Poon,1 Jacky Li,3 Janice Arakawa-Hoyt,7
Yufeng Shen,4 Lawrence Fong,3,7 Lewis L. Lanier,7,8 and Donna L. Farber1,6,9,10,*
1Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY 10032, USA
2Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA
3Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
4Department of Systems Biology, Columbia University, New York, NY 10032, USA
5Department of Immunology, Faculty of Medicine, University of Debrecen and Doctoral School of Cell and Immune Biology, University of
Debrecen, Debrecen, Hungary
6Department of Surgery, Columbia University Medical Center, New York, NY 10032, USA
7Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA 94143, USA
8Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA
9Department of Microbiology and Immunology, Columbia University Medical Center, New York, NY 10032, USA
10Lead Contact
*Correspondence: df2396@cumc.columbia.edu
https://doi.org/10.1016/j.cell.2020.01.022SUMMARY
Immune responses in diverse tissue sites are critical
for protective immunity and homeostasis. Here, we
investigate how tissue localization regulates the
development and function of human natural killer
(NK) cells, innate lymphocytes important for anti-viral
and tumor immunity. Integrating high-dimensional
analysis of NK cells from blood, lymphoid organs,
and mucosal tissue sites from 60 individuals, we
identify tissue-specific patterns of NK cell subset
distribution, maturation, and function maintained
across age and between individuals. Mature and
terminally differentiated NK cells with enhanced
effector function predominate in blood, bone
marrow, spleen, and lungs and exhibit shared tran-
scriptional programs across sites. By contrast, pre-
cursor and immature NK cells with reduced effector
capacity populate lymph nodes and intestines and
exhibit tissue-resident signatures and site-specific
adaptations. Together, our results reveal anatomic
control of NK cell development and maintenance as
tissue-resident populations, whereas mature, termi-
nally differentiated subsets mediate immunosurveil-
lance through diverse peripheral sites.
INTRODUCTION
Natural killer (NK) cells are innate lymphocytes that can directly
kill target cells without any prior exposure while not damaging
healthy ‘‘self’’ cells. Unlike T and B cells that recognize antigen
through clonally distributed, somatically rearranged receptors,
NK cells recognize their targets through integrating signalsfrom multiple germline-encoded activating and inhibitory recep-
tors that recognize major histocompatibility complex class I
(MHC class I) molecules (Colonna et al., 1999; Lanier et al.,
1986). In humans, NK cells (CD3CD56+) are relatively abundant,
comprising 5%–20% of lymphocytes in blood and other sites
(Freud et al., 2017), and play key roles in anti-viral and anti-tumor
immunity. NK cells are required for control of acute and persis-
tent viral infections such as Herpesviruses, and in cancer, NK
cells promote direct lysis of multiple tumor types, and patrol
diverse sites to prevent metastasis (Cerwenka and Lanier,
2001; Imai et al., 2000; Kelly et al., 2002; Morvan and Lanier,
2016; Orange, 2006; Scalzo et al., 2007; Vivier et al., 2012).
These multiple aspects of NK cell functionality indicate their
dynamic role in immune-mediated protection and homeostasis.
It has become increasingly clear that tissue localization is a
critical determinant of the function and in vivo role of lympho-
cytes. Tissue-resident memory T cells (Trm) have been shown
in mouse models to populate barrier, mucosal, and peripheral
sites following antigen encounter, and are required for optimal
protective immunity to pathogens in situ (Jiang et al., 2012; Ma-
sopust and Soerens, 2019;Muruganandah et al., 2018; Schenkel
et al., 2014; Teijaro et al., 2011). In mice and humans, Trm exhibit
cell surface phenotypes and transcriptional profiles distinct from
circulating memory T cells (Gebhardt et al., 2018; Hombrink
et al., 2016; Kumar et al., 2017; Mackay et al., 2016; Szabo
et al., 2019), and Trm are the predominant T cell subset in hu-
mans (Thome et al., 2014). NK cells also populate multiple tissue
sites including liver, lung, skin, kidneys, and bone marrow (BM)
and a proportion express Trm markers CD69 and/or CD103
(Freud et al., 2017; Gaynor and Colucci, 2017; Geissmann
et al., 2005; Hudspeth et al., 2016; Marquardt et al., 2017; Mel-
sen et al., 2018; Montaldo et al., 2016; Shi et al., 2011; Sojka
et al., 2014; Victorino et al., 2015). The role of tissue localization
in human NK cell development and function, and how circulating
NK cells relate to those in different sites, are not well understood.
Human NK cells can be subdivided based on the level ofCell 180, 1–15, February 20, 2020 ª 2020 Elsevier Inc. 1
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Figure 1. Human NK Cell Subset Distribution Is a Function of Tissue Site
(A) Schematic diagram of the human tissues obtained and experimental workflow presented in this study.
(B) Gating strategy used for identification of NK cells and subsets by flow cytometry for analysis and sorting.
(C) NK cell distribution in different human tissue compartments depicted in representative flow cytometry plots (left, D344) showing NK cell
(CD45+CD1419CD3CD56+) frequency, and boxplots of compiled data from 18–55 donors (right). See also Figure S1A, left panel.
(D) Distribution of CD56brightCD16 (light orange) and CD56dimCD16+ (blue) NK cell subsets in multiple sites shown in representative flow cytometry plots (left,
D337 and D344), and boxplots of compiled data from 18–55 donors for each site (right).
(legend continued on next page)
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into two major subsets with distinct maturation and functional
properties (Lanier et al., 1986; Nagler et al., 1989; Yu et al.,
2013). CD56dimCD16+ NK cells are potent cytolytic effector cells,
rapidly secreting pro-inflammatory cytokines (interferon [IFN]-g,
tumor necrosis factor alpha [TNF-a]) and cytotoxic mediators
(granzymes and perforin) following receptor-mediated activa-
tion. By contrast, CD56brightCD16NK cells exhibit reduced lytic
capacity, although can produce IFN-g when stimulated with cy-
tokines, interleukin (IL)-12, and IL-18 (Aste-Amezaga et al., 1994;
Carson et al., 1994; Cooper et al., 2001; Fehniger et al., 1999).
Following stimulation with viruses, cytokines, or haptens, NK
cells can also acquire memory-like properties and enhanced
functional responses similar to adaptive memory T cells (Cooper
et al., 2009; O’Leary et al., 2006; O’Sullivan et al., 2015; Sun
et al., 2009, 2010, 2012). Memory-like NK cells responsive to
cytomegalovirus (CMV) have been identified in mouse models
of MCMV infection and in humans (Arase et al., 2002; Daniels
et al., 2001; Dokun et al., 2001; Guma´ et al., 2004, 2006; Lo-
pez-Verge`s et al., 2011). Understanding the distribution, func-
tion, and development of human NK cell subsets across multiple
tissue sites, age, and individuals will provide essential insights
into their role in immune responses and surveillance.
Here, we investigate how NK cells are distributed across
tissues, ages, and individuals and the impact of tissue site on
NK development and function, using a human tissue resource
we established to obtain blood and multiple tissue sites from in-
dividual organ donors spanning nine decades of human life
(Carpenter et al., 2018; Gordon et al., 2017; Granot et al.,
2017; Kumar et al., 2017).We show that NK cells comprise a size-
able fraction of the lymphocyte compartment in blood, BM,
spleen, and lung, where they are predominantly CD56dimCD16+;
significantly lower frequencies of NK cells populate lymph
nodes (LNs), tonsils, and intestines, and are mostly CD56bright
CD16. This tissue-intrinsic profile of NK cell frequency, subset
distribution, and differentiation states is conserved between
diverse individuals over a lifetime. Using high-dimensional tran-
scriptional and phenotypic profiling, we show that precursor
and immature NK cells in the lymph nodes and intestines exhibit
tissue-residentmolecular signatures and site-specific properties,
whereas mature and terminally differentiated NK cells have
similar effector function and shared gene expression profiles
between sites. Our findings reveal tissue-mediated segregation
of NK cell development and function and provide a blueprint for
how NK cells are seeded, maintained, and surveil tissues across
the body.
RESULTS
Tissue-Intrinsic Distribution of Human NK Cell Subsets
To analyze human NK cell distribution, maturation, function, and
transcriptional profiles across different anatomic sites and com-
partments, we obtained blood, BM, secondary lymphoid organs(E) CD57 expression by CD56bright CD16 (light orange) and CD56dimCD16+ (blue
D345) and compiled data from 13–43 donors (right). See also Figure S1A, right pa
0.001; **p% 0.01; *p% 0.05. Gut refers to both large and small intestines, as we fo
S1C). BM, bone marrow; LLN, lung-draining lymph node; MLN, mesenteric lymp(spleen, lung-draining lymph nodes [LLN], andmesenteric lymph
nodes [MLN]), mucosal tissues (lungs, gut [small and large
intestine]), and tonsils from human organ donors as described
previously (Carpenter et al., 2018; Gordon et al., 2017; Granot
et al., 2017; Kumar et al., 2017; Thome et al., 2014; Figure 1A).
Tissues were obtained from 60 donors ranging in age from
5–92 years and representing a racially and ethnically diverse
population (Table S1). NK cells were distinguished from other
lymphocytes and myeloid lineage cells based on gating for
CD45+CD3CD14CD19CD56+ cells and further delineated
into the major NK subsets, CD56brightCD16 and CD56dimCD16+
(Figure 1B). The tissue distribution of NK cells among CD45+
CD14CD19 cells was consistent between donors with blood,
BM, spleen, and lung having significantly higher frequencies of
NK cells (5%–50%) compared to low frequencies (<0.1%–2%)
of NK cells in the LNs, tonsil, and gut (Figure 1C and see Fig-
ure S1A, left panel for individualized data for each site per donor).
BM contained a broader range of NK cell frequencies compared
to other sites (Figure 1C), and donors with high NK cell content
in BM also showed higher NK frequencies in blood, spleen,
and/or lung (Figure S1A, left).
The distribution ofCD56brightCD16 andCD56dimCD16+NKcell
subsets was also a feature of the tissue site; CD56brightCD16 NK
cells predominated in LNs, tonsil, and gut while the majority of NK
cells in blood, BM, spleen, and lung were CD56dimCD16+ as
shown in compiled data (Figure 1D) and for each individual donor
(Figure S1A, middle panel). CD56dimCD16+ NK cells can be
further subdivided into a terminally differentiated subset identified
by CD57 expression, resulting from persistent stimulation by
antigens or inflammatory signals (Bjo¨rkstro¨m et al., 2010; Lopez-
Verge`s et al., 2010). The extent of CD57 expression by
CD56dimCD16+ NK cells varied between sites: substantial fre-
quencies (50%–70%) were CD57+ in blood, BM, spleen, and
lung, while lower frequencies of CD57-expressing CD56dimCD16+
NKcells were present in LNs, tonsils, and gut (Figures 1E andS1A,
right). These data further indicate that terminal differentiation of
NK cells is more prevalent in sites containing an abundance of
CD56dimCD16+ NK cells (blood, BM, spleen, and lungs), and
excluded from sites such as LN and intestines.
Role of Age, Sex, and CMV Status on NK Cell Subset
Distribution
We investigated whether the overall distribution of NK cells or
NK cell subsets in tissues varied according to age or CMV
serostatus, which are known to affect lymphocyte subset
differentiation and immunosenescence (Nikolich-Zugich, 2018;
Pawelec and Derhovanessian, 2011). For determining age-
associated effects, we performed a correlation analysis of NK
cell and subset frequencies as a function of age, revealing
consistent, site-specific frequencies of total NK cells and
CD56brightCD16:CD56dimCD16+ subset ratios from childhood
to advanced ages (Figures 2A and 2B). Accordingly, the fre-
quency and tissue distribution of NK cells and CD56dim/bright) NK cell subsets shown in representative flow cytometry plots (left, D344 and
nel. Dots on the boxplots show data collected for each individual donor. ***p%
und similar NK cell and subset frequencies for these two sites (Figures S1B and
h node.
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Figure 2. NK Cell Subset Distribution in Tissues Is Independent of Age, Sex, and CMV Serostatus
(A) Scatterplots showing frequency of NK cells in blood and tissue sites as a function of age for each individual donor. The line of best fit was determined by
Pearson correlation; the Pearson correlation coefficient for each comparison is designated as ‘‘pearsonr’’ in each plot (left). Right: NK cell frequency in different
sites in donors stratified by CMV serostatus (CMV+, seropositive; CMV, seronegative) and sex (male or female).
(B) Scatterplots showing the ratio of CD56dimCD16+:CD56brightCD16NK cells in blood and tissue sites as a function of age for each donor, with line of best fit and
Pearson coefficient indicated as in (A). See also Figure S1A, middle panel. Right: the ratio of CD56dimCD16+:CD56brightCD16 NK cells in different sites in donors
stratified by CMV serostatus (top) and sex (bottom).
(C) Scatterplots showing the distribution of terminally differentiated NK cells (CD56dimCD16+CD57+) in blood and tissue sites as a function of age for each donor;
the line of best fit and Pearson correlation coefficient indicated in each plot (left). See also Figure S1A, right panel. Right: the distribution of terminally differentiated
NK cells in different sites in donors stratified by CMV serostatus (top) and sex (bottom).
(D) Representative flow cytometry plots (left) showing the distribution of CMV-responsive (CD56dimCD16+CD57+NKG2C+) memory-like NK cells in a repre-
sentative CMV-seronegative (CMV, D344) and CMV-seropositive donor (CMV+, D349). Right: boxplots showing compiled distribution of CMV-responsive NK
cells from HLA: C1, Bw4/C1, Bw4/C2, and Bw4/C1/C2 CMV+ (n = 12–17) and CMV (n = 9–12) donors, data between the groups was compared using Mann-
Whitney U test. See also Figure S2A. Dots on the boxplots show data collected for each individual donor. **p% 0.01; *p% 0.05; ns, non-significant. BM, bone
marrow; LLN, lung-draining lymph node; MLN, mesenteric lymph node.
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https://doi.org/10.1016/j.cell.2020.01.022subsets did not vary significantly with CMV serostatus or sex of
the donor (Figures 2A and 2B), consistent with NK cells being a
component of innate immunity. The frequency of terminally
differentiated CD56dimCD16+CD57+ NK cells showed a positive
correlation with age in blood, BM, spleen, and lung, which
achieved significance in the BM (p = 0.05; lung, p = 0.06), but
showed no significant correlation with sex or CMV serostatus
(Figure 2C). These results show minimal overt effects of age
(over nine decades) and CMV serostatus on the global and
site-specific distribution of NK cell subsets, but age-related ef-
fects on the accumulation of terminally differentiated NK cells
in certain key sites.4 Cell 180, 1–15, February 20, 2020To further investigate effects of CMV seropositivity on NK cell
subsets across sites, we probed for the presence of memory-
like NK cells exhibiting CD56dimCD16+CD57+NKG2C+ pheno-
types that were previously shown to delineate CMV-responsive
NK cells (Hendricks et al., 2014; Lopez-Verge`s et al., 2011).
CMV-responsive NK cells were detected reliably in blood, BM,
spleen, and lung (but not LN, tonsil, or gut) of CMV-seropositive
donors but not significantly in CMV-seronegative donors, (Fig-
ure 2D). The presence of CD57+NKG2C+ NK cells was also
associated with certain HLA types, with a strong association
with HLA-Bw4 and HLA-C1/C2 group antigens (Faridi and
Agrawal, 2011; Figure S2A). These data indicate that the
Please cite this article in press as: Dogra et al., Tissue Determinants of Human NK Cell Development, Function, and Residence, Cell (2020),
https://doi.org/10.1016/j.cell.2020.01.022accumulation of CMV-responsive memory-like NK cells occurs
in blood and blood-rich sites (BM, spleen, and lung) in a subpop-
ulation of seropositive individuals.
Tissue Site Shapes the Functional Potential of NK Cell
Subsets
NK cells acquire granzyme B (GzmB) expression during the
maturation process, and GzmB is one of the main cytolytic
effector molecules produced by activated NK cells (Fehniger
et al., 2007). When stained directly ex vivo, there was biased
expression of GzmB (40%–80% GzmB+) in CD56dimCD16+
compared to CD56brightCD16 NK cells across blood and all tis-
sue sites examined (Figure 3A). Between sites, the frequency of
GzmB+ in CD56dimCD16+ NK cells is significantly higher in the
lung compared to LNs and gut (Figure 3A). GzmB expression
by CD56dimCD16+ NK cells is unaffected by age of the donors
(Figure S2B). These results suggest conserved functional dichot-
omies between NK cell subsets across tissues, but tissue-
specific variations in cytotoxic potential.
Antibody-mediated crosslinking of CD16 on NK cells elicits
antibody-dependent cellular cytotoxicity (ADCC) through
association of CD16 with the signaling adaptors FcεRIg or
CD3z (Lanier et al., 1989; Wang et al., 2015). The level of FcεRIg
expression is an indicator of ADCC capacity; NK cells that
downregulate FcεRIg and upregulate CD3z expression exhibit
the most potent ADCC effector function (Lanier et al., 1989;
Zhang et al., 2013). In all sites, there was a higher frequency
of FcεRIg+ cells within the CD56dimCD16+ compared to
CD56brightCD16 NK subset (Figure S2C, left panel), consistent
with the coordinated expression of FcεRIg and CD16 in NK cells
(Hibbs et al., 1989; Lanier, 2008). However, CMV seropositivity
was associated with a slight increase in the frequency of func-
tionally mature (CD56dimCD16+FcεRIg) NK cells (Figure S2C,
right panel), consistent with the known effects of CMVonNKcells
(Lee et al., 2015; Schlums et al., 2015). Therewere tissue-specific
differences in the level of FcεRIg expression; tonsils, gut, and LN
CD56dimCD16+ NK cells express substantially higher levels of
FcεRIg compared to CD56dimCD16+ NK cells in blood, BM,
spleen, and lungs (Figure 3B). Site-specific FcεRIg expression
did not vary with age (Figure S2D), suggesting that mature NK
cells in blood, BM, spleen, and lung exhibit higher ADCCcapacity
compared to those in LN and intestines.
NK cells can also elicit effector function in response to cyto-
kine stimulation (Zwirner and Ziblat, 2017). Culturing NK
cells from blood, BM, spleen, lung, and LLNs with a cytokine
cocktail (IL-12, IL-15, and IL-18) induced IFN-g production
with site-specific differences; BM NK cells had the highest fre-
quency of IFN-g producers followed by spleen, lung, and
blood, with LN having the lowest frequency (Figure 3C). We
also tested the functional potential of NK cells activated in
the presence of a MHC class I-negative tumor cell line in vitro
by staining for the expression of lysosomal-associated mem-
brane protein 1 (LAMP-1: CD107a), a marker for degranulation
(Alter et al., 2004). NK cells from all the sites showed similar
CD107 expression and degranulation potential. Together, these
functional analyses indicate site-specific variations in NK
cell effector function, particularly in the capacity for cytokine
production.Whole Transcriptome Profiling Uncovers Subset- and
Tissue-Specific Features of NK Cells
To identify the molecular basis of differential tissue distribution
and functionality between NK cell subsets, we performed whole
transcriptome profiling by RNA sequencing (RNA-seq) of
CD56brightCD16 and CD56dimCD16+ NK cells sorted from
blood, BM, spleen, lung, and LLN. Analysis of the whole
transcriptome identified global signatures of 1,083 genes
differentially expressed (DE) between CD56brightCD16 and
CD56dimCD16+ NK cells (702 upregulated and 381 downregu-
lated; Table S2) from these sites. Principal component analysis
(PCA) shows subset and tissue-specific distinctions. Along
PC2, the transcriptional profile of CD56brightCD16NKcells clus-
tered separately from that of CD56dimCD16+ NK cells in all the
sites sampled, indicating distinct transcriptional profiles for
each subset across sites (Figure 4A; see Figure S3A right
for top PC2 loadings). Along PC1 within each subset,
blood, BM, and spleen samples clustered together and distinct
from lung and LLN samples (Figure 4A). The top genes within
the common global signature of DE genes between CD56bright
CD16 and CD56dimCD16+ NK cells from all sites is depicted
in the heatmap in Figure 4B and includes genes associated
with immune signaling and function as identified by Gene
Ontology analysis (Table S3).
The global gene expression differences we identified between
CD56brightCD16 and CD56dimCD16+ NK cells were conserved
in all sites, revealing subset-specific profiles consistent with
previous studies of NK subsets from single sites (Collins et al.,
2019; Koopman et al., 2003; Marquardt et al., 2019; Melsen
et al., 2018). Genes upregulated in CD56dimCD16+ NK cells
include those associated with effector function (GZMB, GZMH,
IFNG), killer cell immunoglobulin-like receptors (KIR), and tissue
egress and circulation (S1PR5, S1PR1, CXCR1, CXCR2, and
CX3CR1), while CD56brightCD16 NK cells express elevated
levels of genes associated with immune regulation (CD27,
TNFSF4, TNFSF8, TNFSF13, and TNFSF13B) and tissue
homing (CCR7, SELL, CXCR3, and CCR5) (Figure S3B).
CD56brightCD16 NK cells expressed genes encoding tran-
scription factors involved in cellular stemness and quiescence
(Kuo and Leiden, 1999; Zhou et al., 2010) including LEF1 and
TCF7 (TCF-1), while CD56dimCD16+ NK cells, expressed genes
encoding transcription factors associated with terminal differ-
entiation and effector function including TBX21 (T-bet), ZEB2,
and IRF6 (Figure 4C). Differential expression of TCF-1 and
T-bet in CD56brightCD16 compared to CD56dim CD16+ cells
in different sites was confirmed by flow cytometry (Fig-
ure S3C, top and bottom, respectively). Together, these ana-
lyses demonstrate that the core transcriptional identities of
CD56brightCD16 and CD56dimCD16+ NK subsets are main-
tained in diverse anatomical sites.
NK cell subsets also exhibited site-specific variations in their
transcriptional profile. Comparing the transcriptional profiles of
tissue CD56brightCD16 and CD56dimCD16+ NK cells to their
counterparts in blood identifies unique DE genes in tissue NK
cell subsets (Figure S4A; Tables S4 and S5). Gene set
enrichment analysis (GSEA) further reveals subset- and tissue-
specific gene expression programs; both NK cell subsets in
LLN were enriched for regulatory and tissue retention pathways,Cell 180, 1–15, February 20, 2020 5
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Figure 3. Tissue Localization Shapes the Functionality of NK Cells
(A) Expression of granzymeB (GzmB) by NK cell subsets in different tissue compartments shown in representative histograms (left, D455 and D456) and graphs of
compiled frequency of GzmB+ NK cell subsets from 8–19 donors (right). See also Figure S2B.
(B) Expression of the CD16 adaptor molecule FcεRIg by NK cell subsets in different sites shown in representative histograms (left, D344); numbers in each plot
represent median fluorescence intensity (MFI) of FcεRIg for each subset (light orange, CD56brightCD16; blue, CD56dimCD16+). Boxplots (right) show DMFI
FcεRIg (compiled from 10–25 donors) calculated by subtracting the FcεRIgMFI of control (CD3+) cells from the FcεRIgMFI of each NK cell subset. Comparison of
DMFI from CD56dimCD16+ cells between LN and gut versus blood, BM, spleen, and lung indicated by red asterisk.
(C) IFN-g secretion following culture of sorted NK cells from indicated sites with cytokines (see STAR Methods) shown as representative histograms (left, D388),
and boxplots showing frequency of IFN-g+ NK cells for each site compiled from 4–7 donors (right).
(D) CD107a expression following activation of NK cells from indicated sites by co-culture with K562 cells for 4 h (see STAR Methods) shown as representative
histograms (left, D454), and boxplots showing frequency of CD107a+ NK cells for each site compiled from 8–13 donors (right). Dots on the boxplots show data
collected for each individual donor. ***p% 0.001; **p% 0.01; *p% 0.05. BM, bone marrow; LLN, lung-draining lymph node; MLN, mesenteric lymph node.
Please cite this article in press as: Dogra et al., Tissue Determinants of Human NK Cell Development, Function, and Residence, Cell (2020),
https://doi.org/10.1016/j.cell.2020.01.022while in the lung, CD56brightCD16 NK cells were enriched for
cell-adhesion and chemotaxis pathways, and CD56dimCD16+
NK cells were enriched for effector functional programs
compared to other sites (Figures S4B and S4C). Moreover,6 Cell 180, 1–15, February 20, 2020PCA analysis for the individual subsets revealed more site-spe-
cific differences among CD56brightCD16 NK cells compared
to CD56dimCD16+ NK cells. In particular, the transcriptional pro-
file of CD56brightCD16 NK cells from blood, BM, and spleen
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Figure 4. Transcriptional Analysis of CD56brightCD16 and CD56dimCD16+ NK Cells across Sites
(A) PCA plot generated from top 500 differentially expressed (DE) genes between CD56brightCD16 and CD56dimCD16+ NK cell subsets isolated from 5 sites
(blood, BM, spleen, lung, and lung-draining LN). See Table S2 for complete gene list.
(B) Heatmap of top 50 globally DE genes between CD56brightCD16 and CD56dimCD16+ NK cell subsets from all sites.
(C) Heatmap showing the top DE transcription factors between CD56brightCD16 and CD56dimCD16+ NK cells from all sites.
(D) PCA plot for CD56brightCD16 (top) and CD56dimCD16+ (bottom) NK cells isolated from five sites. Each dot in the PCA plots is a separate donor sample, and
ellipses around samples indicate 95% confidence ellipses (see STARMethods). B, blood; M, bone marrow; S, spleen; L, lung; N/LLN, lung-draining lymph node.
See also Figures S3 and S4.
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Figure 5. Tissue Residence Profile of CD56brightCD16 NK Cells
(A) GSEA plot showing the enrichment of core tissue resident-memory T (Trm) cell genes within CD56brightCD16 NK cells from all tissue sites. See also
Figure S5A.
(B) Heatmap showing the expression of select core Trm signature genes differentially expressed in tissue CD56brightCD16 NK cells and not expressed in blood
CD56brightCD16 or CD56dimCD16+ NK cells in all sites.
(C) Cell surface expression of canonical tissue residencemarkers CD69 andCD103 on CD56brightCD16 (light orange) and CD56
dim
CD16+ (blue) NK cell subsets in
different tissue compartments shown in representative flow cytometry plots (top, D337 and D351) and boxplots showing percent CD69+NK cells within each
subset in different tissue compartments compiled from 18–40 donors. Dots on the boxplots show data collected for each individual donor. See also Figure S5B.
***p% 0.001; **p% 0.01. B, blood; M/BM, bone marrow; S, spleen; L, lung; N/LLN, lung-draining lymph node; MLN, mesenteric lymph node.
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https://doi.org/10.1016/j.cell.2020.01.022clustered separately on the PCA plot, whereas CD56dimCD16+
NK cells from these sites clustered together (Figure 4D). In
contrast, the transcriptional profile of both CD56brightCD16
and CD56dimCD16+ NK cell subsets in the lung and LLN were
distinct from the corresponding subsets in blood and other tis-
sue sites (Figure 4D) and showed increased sharing of transcrip-
tional programs compared to these sites (Figures S4D and S4E).
These results suggest a common origin for NK cells that populate
the lung and the LLN. Taken together, our findings reveal that
although NK cell subset transcriptional identity is preserved
across sites, tissue localization drives further subset-specific
transcriptional programs in NK cells.
CD56brightCD16 NK Cells in Tissues Exhibit a Tissue-
Resident Gene Expression Signature
We hypothesized that the tissue-adapted gene expression
programs of CD56brightCD16 NK cells derives from their
residence in tissues. GSEA comparing the transcriptome of
CD56brightCD16 NK cells to the Trm gene signatures we previ-
ously identified in human tissue sites (Kumar et al., 2017) re-
vealed significant enrichment of core signature genes of human8 Cell 180, 1–15, February 20, 2020lung and spleen CD8+Trmwithin CD56brightCD16NK cells in tis-
sues (Figure 5A). Core Trm gene expression signatures including
upregulation of the integrin ITGAE (CD103), ITGA1, and the che-
mokine receptor CXCR6 and downregulation of tissue egress
molecules S1PR1 and KLF2 (Kumar et al., 2017), distinguished
tissue CD56brightCD16 NK cells from CD56brightCD16 NK cells
in blood and CD56dimCD16+ NK cells in all sites (Figure 5B).
There were also site-specific variations in the extent of expres-
sion of certain core genes incusing CXCR6, ITGA1, and ITGAE
(Figure S5A), suggesting tissue-specific effects on the establish-
ment of residency programs.
The expression of canonical TRM surface markers CD69 and
CD103 by tissue NK cells showed subset- and site-specific var-
iations. In BM, spleen, lungs, and tonsils, CD69 was expressed
by significantly higher frequencies (35%–90%) of CD56bright
CD16 compared to CD56dimCD16+ NK cells; however, in gut
and LN, CD56brightCD16 and CD56dimCD16+ NK cell subsets
exhibited comparable CD69 expression (Figure 5C). In mucosal
sites (lungs, intestines) substantial frequencies of CD69+ NK
cells co-expressed CD103 (Figure 5C). The frequency and
distribution of CD69 expression by CD56brightCD16 NK cells
AB
Figure 6. Heterogeneity of Tissue Resident NK Subsets across Sites
(A) Representative SPADE plots of NK cells from blood, BM, spleen, lung, gut, LLN, and MLN stained with tissue-residence markers. The two plots on the left
show the distribution NK cells along the maturation axis. The plots on the right show the expression and distribution of select residence markers and marker for
terminal differentiation on NK cells along the maturation axis. Solid black arrow identifies CD103- and CD49a-expressing NK cell cluster and dashed black arrow
identifies the CXCR6-expressing NK cell cluster. See also Figure S5C.
(B) Boxplots showing the distribution of CD69+CD103+CD49+CXCR6 (left) and CD69+CD103CD49aCXCR6+ (right) CD56brightCD16, NK cells in indicated
tissue sites compiled from 5–10 donors. Dots on the boxplots show data collected for each individual donor. Red asterisk, comparison between lung and tissue
site; purple asterisk, comparison between gut and tissue site; orange asterisk, comparison between BM and tissue site; green asterisk, comparison between
spleen and tissue site. ***p% 0.001; **p% 0.01; *p% 0.05. BM, bone marrow; LLN, lung-draining lymph node; MLN, mesenteric lymph node.
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tissue residence is an intrinsic property. These findings show
that CD56brightCD16 NK cells exhibit features of tissue resi-
dency in multiple sites, whereas CD56dimCD16+ NK cells bear
signatures of circulating cells in blood, BM, and spleen, but
can adopt resident phenotypes in LN and mucosal sites.
Tissue-Specific Properties andHeterogeneity of Tissue-
Resident Cells
We assessed coordinate expression of key tissue residency
markers CD69, CD103, CD49a, and CXCR6 (Kumar et al.,
2017; Peng and Tian, 2017) to further investigate site-specific
differences as suggested by the transcriptional data (Figure S5A)and define potential heterogeneity of putative tissue-resident
NK (trNK) cells in different anatomical sites. Spanning-tree
progression analysis of density-normalized events (SPADE)
(Qiu et al., 2011) projection of NK cells from blood, BM, spleen,
lung, gut, LLN, and MLN identified distinct branches of
CD56brightCD16 NK cells that exhibit site-specific variations in
expression of tissue-resident markers, consistent between five
individual donors (Figures 6A and S5C). CD69 expression was
detected in the majority of CD56+ NK cells, except for a specific
branch of cells expressing the highest levels of CD56 that lack
CD69 (Figures 6A and S5C), and may represent a circulating
subset of immature NK cells. Other tissue-resident markers
were differentially expressed; CXCR6 expression was exclusiveCell 180, 1–15, February 20, 2020 9
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BM, spleen, and LNs, while CD49a and CD103 were expressed
together on subsets of CXCR6CD69+NK cells in the lung and
gut (Figures 6A, 6B, and S5C). These site-specific variations in
CXCR6, CD49a, and CD103 expression in trNK subsets are
consistent with variations in expression of the corresponding
genes between sites (Figures 5B andS5A) and reveal tissue-spe-
cific segregation of trNK subtypes.
Maturation and Developmental States of NK Cells
across Tissues
NK cells undergo progressive development from CD56bright
into CD56dim NK cells, involving expression of specific receptors
associated with distinct maturation states (Abel et al., 2018;
Scoville et al., 2017). For example, CD161 is one of the
earliest markers expressed on NK cells during maturation
from CD34+ hematopoietic stem cell precursors; inhibitory and
activating receptors CD94/NKG2A, NKp46, NKp44, CD160,
and NKG2D can be variably expressed in different maturation
states, while expression of CD16 and multiple KIRs mark mature
NK subsets, and CD57 indicates terminal differentiation. In
order to trace the developmental origin of NK cell subsets in
tissues, we implemented a high-dimensional flow cytometry
panel incorporating multiple NK functional and developmental
markers (Figure S6; Key Resources Table).
Force-directed clustering analysis of NK marker expression
data from seven sites (blood, BM, spleen, lung, gut, LLN, and
MLN) of five individuals generated 15 distinct NK cell clusters
that were consistent between donors (Figures 7A and 7B; Table
S6). There were 7 clusters within the CD56bright population: cells
in clusters 1 and 2 express CD56, CD127, and CD161. Cluster 1
cells also express very low levels of activating receptor NKp44
and resemble NK-precursor-like cells described previously (Di
Santo and Vosshenrich, 2006; Freud et al., 2005; Scoville
et al., 2017), while cluster 2 cells exhibit increased expression
of CD56 and NKG2A (Figures 7A and 7C). The remaining
CD56bright cells in clusters 3–7 lack CD127 expression and
show reduced NKp44 expression (except in cluster 3) but ex-
press the activating receptor NKG2D, the inhibitory receptor
NKG2A, and variable levels of NKp46, CD160, and CD161 (Fig-
ures 7A, 7C, and S6). CD56dimCD16+ (mature) NK cells partition
into 8 clusters (clusters 8–15) showing a progressive loss of
CD160, CD161, NKp46, NKG2D, and NKG2A expression, and
concomitant upregulation of CD57 and KIRs along the matura-
tion axis (Figure 7A). Themoremature CD56dim NK cells (clusters
13,14,15) resemble terminally differentiated NK cells exhibiting
upregulated expression of CD57, KIRs, and downregulation of
CD27 (Figures 7A and 7C). Therefore, multiple states of NK
development and differentiation can be detected across blood
and tissues.
The distribution of NK cell maturation states was site-specific.
BM and spleen contained the most heterogeneous composition
of NK cells, comprising multiple maturation states, including
precursor NK cells (clusters 1 and 2), three immature subsets
(clusters 5–7), and all eight clusters that defined the mature
CD16+ population (Figure 7D). Conversely, NK subsets in
blood and lung consisted largely of mature and terminally
differentiated states, particularly in the lung where clusters 13–10 Cell 180, 1–15, February 20, 202015 predominated. By contrast, immature subsets populating
LLN and MLN contained the two precursor subsets
(CD56brightCD127+CD161+) along with lower frequencies of five
immature NK cell states (clusters 3–7) (Figure 7D; Table S6).
Although CD127 is also a marker for innate lymphoid cells (ILC)
(Vivier et al., 2018), we did not detect substantial frequencies
of CD127+ RORgt+ ILC3s (Li et al., 2018; Yudanin et al., 2019)
among CD56+ cells from LLN, gut, and spleen or the other sites
examined (Figure S7A). Moreover, the transcriptional profile of
spleen and LLN NK cell subsets (Figure 4) was distinct from
that of human ILC subsets in different sites recently reported (Yu-
danin et al., 2019; Figure S7B). Together, these data provide
further evidence that the prevalent NK populations in LN likely
represent precursor NK cells and NK subsets maintained in
less differentiated states compared to other peripheral sites.
Last, we identified only two NK cell states in the gut
(clusters 3 and 4) that were not found in the other sites
except for low frequencies, specifically in the gut-draining
MLN, and not in LLN. Cluster 3 cells exhibited a distinct
NKp44+NKp46+CD160+CD294loNKG2A phenotype, whereas
cluster 4 cells lacked expression of NKp44, NKp46, and
CD160, but exhibited upregulated expression of CD85j, an
MHC class I-binding immunoglobulin-like molecule with inhibi-
tory activity (Colonna et al., 1997). These distinct NK cell
subsets appear to be specific or enriched within intestinal sites
(and intestinal LN) because in the donors from whom we did
not obtain intestinal tissues (donors 1–3; Figure 7B), these
clusters were not observed. This high-dimensional analysis
of NK cells across multiple tissues within individual donors
demonstrate tissue-specific distribution of developmental
and functional states of NK cells and identifies the LN and intes-
tines as reservoirs for specific populations of precursor and
immature NK cells, respectively.
DISCUSSION
We reveal here the role of tissue localization in the develop-
ment, function, and transcriptional program of NK cells, critical
innate lymphocytes that mediate control of viral infections and
tumors. Analysis of primary and secondary lymphoid organs as
well as mucosal sites obtained from 60 organ donors
shows that the tissue distribution of human NK cells and
major NK cell subsets is a function of the tissue site and is
unaffected by age, sex, and CMV serostatus. NK cells are
most abundant in blood, BM, spleen, and lung, which are
dominated by mature (CD56dimCD16+), terminally differenti-
ated (CD56dimCD16+CD57+), and CMV-responsive (CD56dim
CD16+CD57+NKG2C+) NK cell subsets with high effector func-
tion. Significantly lower frequencies of NK cells are found in
LN, tonsils, and intestines comprising mostly immature
(CD56brightCD16) subsets with reduced effector capacity,
which exhibit features of tissue-resident lymphocytes and tis-
sue-specific adaptations. Moreover, developmental lineages
of NK cells exhibit site-specific distribution and phenotypes;
NK cell precursors and immature tissue-adapted subsets
localize in LN and intestines; spleen and BM contain all devel-
opmental stages, whereas lung has prevalent mature and
terminally differentiated NK cells. Together, our results
Figure 7. High-Dimensional Flow Cytometry Profiling Identifies Tissue-Specific Patterns of NK Development and Maturation
NK cells from blood, bone marrow (BM), spleen, lung, gut, lung-draining LN (LLN), and mesenteric LN (MLN) were stained with the high-dimensional antibody
panel specific for multiple NK cell maturation and function markers (see STAR Methods). See also Figure S6.
(A) Force-directed plot showing the relationship between different NK cell communities identified by multi-dimensional analysis (data compiled from 5 donors).
Each node is an aggregation of similar cells resulting from downsampling of data, and collection of similar colored nodes forms 15 distinct NK cell clusters.
Colored text boxes show markers used to differentiate each cluster (1–15).
(B) Plots showing the distribution of NK cell communities across the five donors.
(C) Heatmap showing the differential expression of cell surface markers used for clustering and community identification in the multi-dimensional analysis in (A).
(D) Scatterplots showing distribution of NK cell states in each tissue among the clusters identified by multi-dimensional analysis. For (B) and (D), colored shapes
delineate boundaries corresponding to each cluster identified in (A).
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development, function, and immunosurveillance.
Our tissue resourceenablesassessmentof immunecells across
sites within and between individuals, for unambiguous determina-
tion of attributes that are tissue-intrinsic versus those that vary due
toage, sex, or between individuals.Asshownhere, thedistribution
of NK cells and subsets and their intrinsic function are features of
the tissue site and are remarkably consistent between donors in-
dependent of age or sex, consistentwith their role as an innate im-
mune cell. Notably, the majority of NK cells localize in the blood,
and blood-rich sites such as BM, spleen, and lungs where they
are largely CD56dimCD16+ cells with high effector capacity—a
subset predominance consistent with previous studies of human
NK cells (Castriconi et al., 2018; Freud et al., 2017; Robertson
and Ritz, 1990). Terminally differentiated and memory-like NK
cells, including CMV-responsive NK cells, also predominate in
these blood-rich sites. By contrast, NK cells are present only at
low frequencies in LNs, tonsils, and throughout the GI tract where
they are predominantly CD56brightCD16 cells, while mature and
terminally differentiated NK cells are largely excluded from these
sites. This compartmentalization of NK cell subsets may occur
due to seeding of distinct subsets directly from the BMor differen-
tial migration of NK populations during maintenance.
We show here that CD56brightCD16 NK cells in lymphoid and
mucosal tissues exhibit key transcriptional and functional fea-
tures of Trm cells (Kumar et al., 2017; Mackay et al., 2016; Maso-
pust and Soerens, 2019). In contrast to T cells where tissue
residency is acquired during differentiation to memory T cells,
tissue residency in NK cells is a feature of the less differentiated
subset, consistent with recent results in human BM and lung
(Marquardt et al., 2019; Melsen et al., 2018). By contrast,
CD56dimCD16+ and memory-like NK cells exhibit features of
circulating cells and are prevalent in blood-rich sites. We also
show that trNK cells exhibit site-specific transcriptional
and phenotypic adaptations. In particular, CD56brightCD16 cells
from LN and lung were transcriptionally distinct compared to
BM and other sites, due in part to differential expression of
residency markers CD49a, CD103, and CXCR6 and multiple
chemokine and homing receptors. Together, these data provide
strong evidence for differential requirements for NK cell homing
and/or retention in distinct tissue sites.
The diversity in NK cell phenotypes is driven by the differential
expression of developmentally regulated receptors, which also
govern the functional responsiveness of NK cells (Colonna
et al., 1999; Lanier et al., 1986; Pegram et al., 2011). Our high-
dimensional analysis of multiple NK cell lineage markers
revealed tissue-specific patterns of NK development and
function. At the earliest differentiation states, CD127+NKp44low
NK precursor-like cells were predominant in LNs and were
similar to those identified as stem cell-derived and thymus-
derived NK cells (Freud et al., 2005; Luther et al., 2011; Vosshen-
rich et al., 2006). LN also contain additional immature subsets
(CD16CD160lowKIRlow), which express transcripts encoding
chemokines (e.g.,XCL1,XCL2, andCCL5) for recruitment of lym-
phocytes and myeloid cells (Bottcher et al., 2018), and resemble
theNK2 subset recently described (Crinier et al., 2018). Intestines
also harbor immature subsets, but maintain predominantly two
specific types not found in blood or other tissues that are also12 Cell 180, 1–15, February 20, 2020found in gut-associated LN. One of the intestine-specific subsets
exhibits co-expression of NKp44 and NKp46 and may resemble
NK cell phenotypes associated with inflammatory bowel disease
(Poggi et al., 2019). Interestingly, the blood, BM, and spleen
contain a range of NK cell subsets and differentiation states
expressing a range of KIRs, NCRs, and activating receptors,
consistent with previously defined heterogeneity among blood
NK cells (Bengsch et al., 2018; Horowitz et al., 2013), while lung
is enriched in highly differentiated NK cells.
Together, our results suggest a model for anatomic control of
NK cell development and function. Specifically, precursor and
immature NK cells are seeded into LNs and intestines where
they take up residence, and these sites may therefore serve as
reservoirs for NK cell maintenance. Activation and differentiation
of NK cells triggers dispersal into other sites including spleen,
blood, and lung, where they conduct immunosurveillance
and mediate effector function. In this way, NK cells control
virus infections and tumors in sites readily accessible to circula-
tion such as BM and lungs, while intestines and secondary
lymphoid sites may be less amenable to NK cell-mediated im-
mune surveillance. This site-specific segregation of NK cell
maintenance and differentiation is consistent with the preferen-
tial role of NK cells in controlling the dissemination of infected
cells and tumor cell metastasis (Morvan and Lanier, 2016).
In conclusion, tissue-intrinsic modes of NK cell maintenance,
differentiation, and functional regulation revealed here can drive
future efforts to develop anti-tumor and anti-viral immunother-
apies to leverage these distinct features of NK cell immunity.
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Deposited Data
Raw and analyzed data This paper GEO: GSE133383
Experimental Models: Cell Lines
K652 cell line ATCC Cat#ATCC CCL-243
Software and Algorithms
STARaligner https://github.com/alexdobin/STAR Dobin et al., 2013
DEseq2 N/A Love et al., 2014
Enrichr https://amp.pharm.mssm.edu/Enrichr/ Chen et al., 2013
WebGestalt http://www.webgestalt.org/ Wang et al., 2017
Rstudio version 1.2.1335 RStudio, Inc. (2019) https://rstudio.com
R version 3.5 R Foundation for StatisticalComputing (2017) https://www.R-project.org
Other
EasySep Human NK Cell Enrichment Kit Stem Cell Tech Cat#19055
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MATERIALS AVAILABILITY STATEMENT
This study did not generate new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human samples
Tissues were obtained from deceased organ donors as part of organ acquisition for clinical transplantation through an approved
protocol and material transfer agreement with LiveOnNY as described previously (Carpenter et al., 2018; Gordon et al., 2017; GranotCell 180, 1–15.e1–e4, February 20, 2020 e2
Please cite this article in press as: Dogra et al., Tissue Determinants of Human NK Cell Development, Function, and Residence, Cell (2020),
https://doi.org/10.1016/j.cell.2020.01.022et al., 2017; Kumar et al., 2017; Miron et al., 2018; Senda et al., 2019). Donors were free of cancer, chronic diseases, seronegative for
hepatitis B, C, and HIV, and represented diverse ages (Table S1). This study does not qualify as ‘‘human subjects’’ research, as
confirmed by the Columbia University IRB as tissue samples were obtained from brain-dead (deceased) individuals.
METHOD DETAILS
Isolation and preparation of single cell suspensions from tissue samples
Tissue samples were maintained in cold saline or CoStorSol (University of Wisconsin (UW) solution (Preservation Solutions,
Elkhorn, WI, Cat# PS004)), and transported to the laboratory within 2-4 hours of organ procurement. Lymphocytes were isolated
from blood and BM samples by density centrifugation using lymphocyte separation medium (Corning cat# 25-072-CI) for recovery
of mononuclear cells. Spleen, lung, intestinal, tonsil, and LN samples were processed using enzymatic and mechanical digestion,
resulting in high yields of live leukocytes, as previously described (Carpenter et al., 2018; Gordon et al., 2017; Granot et al., 2017;
Kumar et al., 2017; Miron et al., 2018; Senda et al., 2019).
Flow cytometry analysis and cell sorting
For flow cytometric analysis, cells were stained in 96-well U-bottom plates in the dark using antibody panels (see Key Resources
Table). Surface staining was done for 20min at room temperature (RT). For intracellular staining, surface stained cells were fixed
for 25min at RT in fixing buffer (Invitrogen cat# 00-5123-43), followed by staining in permeabilization buffer (Invitrogen cat#
00-8333-56) at RT for 30 min. Controls were isotype stained and single-fluorochrome stained samples. Flow cytometry data were
acquired on a BD LSRII and analyzed using FCS express 6 (De Novo Software) and custom Python scripts. Spanning-tree progres-
sion analysis of density-normalized events (SPADE) analysis of the NK cell data collected from blood, BM, spleen, lung, gut, LLN, and
MLN was done using MATLAB with no down-sampling and number of clusters set to 150-200 (Qiu et al., 2011).
NK cells were purified from blood, BM, spleen, lung, and LN using EasySep Human NK Cell Enrichment Kit (Stem Cell Tech cat#
19055), followed by sorting. Enriched cells were stained with the antibody panel described in the Key Resources Table. The stained
cells were sorted using a BD Influx Cell Sorter. Sorted cells were used either for functional assays or RNA isolation.
High-dimensional parameter flow cytometric analysis of NK cell subsets
For high parameter analysis using the BD Symphony panels, 5x106 cells from each site were stained in 96 well v-bottom plates
using an optimized antibody panel as described in the Key Resources Table. Briefly, cells were washed with PBS, re-suspended
in 1 mL of viability dye and incubated at RT in the dark for 10 min. Cells were washed once with cold FACS-buffer (PBS with 2%
heat-inactivated FCS and 2 mM EDTA) and stained in a two-step process. First, the cells were resuspended in a staining cocktail
that included the anti-gd TCR antibody (Key Resources Table), human TrueStain FcX (BioLegend, cat: 422302), and mouse serum
(Jackson Immuno Research Labs, cat: 015-000-001) and incubated on ice for 10 min. Second, following incubation, antibodies in
the Key Resources Table were added together with 50 mL of Horizon Brilliant Stain buffer (BD Bioscience, cat: 56379), incubated
for 25min on ice, washedwith FACS-buffer, and fixed in 100 mL of Fluorofix Buffer (BioLegend, cat# 422101). Samples were analyzed
on the LSR Fortessa X50 (‘‘Symphony’’) cytometer (BD Bioscience). Data were analyzed with FlowJo 10.2. NK cell populations
(defined as live, CD45+CD14-CD19-CD3-CD56+ lymphocytes) were exported and high-dimensional analyses were performed using
the R-based workflow publicly available at https://github.com/ParkerICI/flow-analysis-tutorial and https://github.com/ParkerICI.
In vitro cytokine stimulation and functional assays of NK cells
NK cells (CD45+CD56+CD3-) sorted from freshly processed tissue sites (see above) were cultured in 96-well u-bottom plates in
RPMI-1640 medium containing fetal bovine serum (10%) with or without 10ng/ml IL-12 (PeproTech, cat# 200-12), 100ng/ml IL-15
(PeproTech, cat# 200-15) and 100ng/ml IL-18 (MBL International Corp. cat# B001-5) for 18 hours. Vesicular transport was inhibited
by GolgiStop (BD Biosciences, cat# 554724) and GolgiPlug (BD Bioscience cat# 555029) during the last 6 hours of the incubation.
Cell surface and intracellular staining was performed as described above.
For measuring degranulation by NK cells, 30,000-50,000 sorted, overnight rested NK cells were incubated with K562 cells (ATCC:
CCL-243; provided by Emily Mace, Columbia University) at a 2:1 effector to target (NK: K562) ratio in a 96-well tissue culture plate at
37C at 5% CO2 for 4 hours. Anti-CD107a antibody was added to the co-culture at the beginning of the assay. Following incubation,
the cells were washed once with FACS-buffer before acquiring the data. Data were acquired on a BD LSRII and analyzed using FCS
express 6 (De Novo Software).
QUANTIFICATION AND STATISTICAL ANALYSIS
Whole transcriptome profiling of NK cell subsets
RNAwas isolated from sorted CD56brightCD16- and CD56dimCD16+ NK cells using the RNA Easy kit (QIAGEN cat # 74004) and library
preparation was done using the SMART-Seq ultra- low input RNA kit (Takara bio). Samples were sequenced at Genewiz
(South Plainfield, NJ) using a HiSeq2500 system (Illumina). Trimmed paired-end reads were mapped to the Homo sapiens
GRCh38 reference genome available on ENSEMBL using the STAR aligner v.2.5.2b. The gene list was filtered to exclude anye3 Cell 180, 1–15.e1–e4, February 20, 2020
Please cite this article in press as: Dogra et al., Tissue Determinants of Human NK Cell Development, Function, and Residence, Cell (2020),
https://doi.org/10.1016/j.cell.2020.01.022non-coding genes, following which genes with read counts below 5 copies in at least 9 of 30 samples were excluded from the anal-
ysis. Sequencing batch differenceswere removed using sva package (Leek et al., 2019) and differential expression (DE) gene analysis
was done using the DESeq2 (Love et al., 2014) package in R. Genes were considered as significantly differentially expressed if
absolute log2fold change wasR 1 and p value was below the 0.05 threshold. Heatmaps were generated using the pheatmap (Kolde,
2012) package, and PCA plots and log2 fold change bi-plots were generated by use of the ggplot2 package (Wickham, 2016). Clus-
tering groups within PCA was predicted by pcaplot function of the pcaExplorer library (Marini and Binder, 2019). The hit counts table
for the ILC study (GEO: GSE126107) (Yudanin et al., 2019) was downloaded and used to compare the transcriptional profile of ILC
subsets to CD56brightCD16- NK cell subsets from this study.
Gene Set Enrichment Analysis
For gene set enrichment analysis (GSEA) of unique tissue-specific transcriptional programs, differentially expressed genes with
value of log2-fold change R 1 for comparison between tissue CD56
brightCD16- and CD56dimCD16+ NK cells, and their blood
counterparts were used as input to run pre-ranked GSEA using WebGestalt web application (Wang et al., 2017). To test for
enrichment of tissue-residence gene signature, genes ranked by absolute value of log2-fold change between CD56
brightCD16-
and CD56dimCD16+ NK cells was used as input to run pre-ranked GSEA using the Broad Institute GSEA Java web application.
Gene sets were created from lung and spleen CD8+Trm transcription profiles, as previously determined (Kumar et al., 2017).
Statistical Analysis
Graphs were generated using the Python matplotlib library (Hunter, 2007). To compare expression of surface and intracellular
markers across different tissue sites, a one-way ANOVA test was run followed by Tukey’s correction to correct for multiple testing.
For comparing expression of markers between 2 groups within a tissue site we performed either a paired t test, or multiple
comparison t tests with unequal variance. Nonparametric Mann-Whitney U test was used where data showed deviation from
normal distribution as indicated in figure legends. P-values below 0.05 were considered as statistically significant. The statistical
analysis was run using custom scripts based on Python SciPy library (Jones et al., 2001) and Prizm (GraphPad). For all figures
***p% 0.001, **p% 0.01, and *p% 0.05.
DATA AND CODE AVAILABILITY
The processed data and transcriptome dataset generated during this study is available on NCBI GEO with the accession number
GEO: GSE133383.Cell 180, 1–15.e1–e4, February 20, 2020 e4
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Figure S1. NK Cell and Subset Distribution in Different Tissue Sites, Related to Figure 1
(A) Heatmaps showing frequency of NK cells (left), ratio of CD56dimCD16+ to CD56brightCD16- NK cells (middle) and frequency of CD57+CD56dimCD16+ NK cells in
blood and tissue sites for each individual donor reported in this study. Donors are arranged by increasing age and color intensity of each cell is based on row
normalization of (min-max scaled) values. White cells indicate that no sample was obtained for a given donor.
(B) Representative flow plots showing NK cell frequency (top left quadrant) in small and large intestine sites reported in this study on left, and on right bar plots
showing data compiled from 9 donors.
(C) Representative flow plots showing NK cell subset frequency in small and large intestine sites reported in this study on left, and on right bar plots showing data
compiled from 9 donors.
Error bars represent ± SEM, *p% 0.05; ns, non-significant. BM, bone marrow; LLN, lung draining LN; MLN, mesenteric LN.
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Figure S2. Distribution of NK Cell Functional Subsets Based on CMV Exposure and Age, Related to Figures 2 and 3
(A) Boxplot showing frequency of CMV-responsive (CD56dimCD16+CD57+NKG2C+) NK cells compiled from blood, BM, spleen, and lung from donors of indicated
HLA types.
(B) Scatterplots showing the line of best fit for the frequency of GzmB+CD56dimCD16+ NK cells in each tissue site as a function of age; pearsonr indicates the
Pearson correlation coefficient for the comparison.
(C) Boxplot of compiled data from 10-24 donors showing the distribution of FcεRIg-expressing NK cell subsets in different sites (left), and the frequency of
FcεRIgnegativeCD56dimCD16+ NK cells between CMV -seronegative and -seropositive donors in different sites (right). **p% 0.01, *p% 0.05; ns, non-significant.
(D) Scatterplots showing the line of best fit for the frequency of FcεRIg+CD56dimCD16+ NK cells in each tissue site as a function of age; pearsonr indicates the
Pearson correlation coefficient for the comparison.
Dots on the boxplots show data collected for each individual donor. BM, bone marrow; LLN, lung draining LN; MLN, mesenteric LN.
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Figure S3. Differential Expression of Genes and Transcription Factors between CD56brightCD16 and CD56dimCD16+ NK Cells, Related to
Figure 4
(A) Bar plots showing highest/lowest loadings of principal component 1 and principal component 2 for PCA analysis comparing the global transcriptome of
CD56brightCD16- and CD56dimCD16+ NK cells in Figure 4A.
(B) Heatmap showing the differential expression of selected genes between CD56brightCD16- and CD56dimCD16+ NK cell subsets isolated from 5 sites (B = Blood,
M = Bone marrow, S = Spleen, L = Lung and N = LLN) from 3 donors.
(C) Representative histograms and boxplot of compiled data from 5 donors showing TCF1 (top) and Tbet (bottom) expression in NK cells subsets in different
anatomical sites.
*p% 0.05. Diamonds represent outliers in the data. BM, bone marrow; LLN, lung draining LN; MLN, mesenteric LN.
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Figure S4. Tissue-Specific Transcriptional Programs for CD56brightCD16 and CD56dimCD16+ NK Cells, Related to Figure 4
(A) Venn diagrams identifying unique differentially expressed (DE) genes between tissue CD56brightCD16- and blood CD56brightCD16- NK cells (top left) and tissue
CD56dimCD16+ and blood CD56dimCD16+ NK cells (top right); table shows unique upregulated and downregulated genes for tissue CD56brightCD16- NK cells
(bottom left) and tissue CD56dimCD16+ NK cells (bottom right).
(B) Left: Heatmap shows upregulated genes in CD56brightCD16- NK cells in indicated sites. Right: graph shows pathways enriched in Lung and LLN
CD56brightCD16- NK cells determined by GSEA. See Table S4.
(C) Left:Heatmap shows upregulated genes in CD56dimCD16+ NK cells in indicated sites.Right: graph shows pathways enriched in Lung and LLNCD56dimCD16+
NK cells determined by GSEA. See Table S5.
(D) Bi-plots for log2fold change (Fc) in gene expression for lung versus blood and LLN versus blood CD56
brightCD16- NK cells (top) and lung versus blood and LLN
versus blood CD56dimCD16+ NK cells (bottom). Red dots represent genes similarly upregulated in both lung and LLN NK cell subsets (number in top right
quadrant) and blue dots represent genes similarly downregulated in both lung and LLN NK cell subsets (number in bottom left quadrant).
(E) Matrix for the tissue wise comparison of transcriptional profile of CD56brightCD16- NK cells top and CD56dimCD16+ NK cells bottom. Numbers in each box
correspond to number of differentially expressed genes for each comparison. BL, blood; BM, bone marrow; SP, spleen; LU, lung; LLN, lung draining LN.
(legend on next page)
Figure S5. Transcriptional and Phenotypic Analysis of Tissue-Resident NK Cells in Different Sites, Related to Figures 5 and 6
(A) GSEA plot showing the enrichment of spleen CD8 tissue resident-memory T (Trm) gene signature within CD56brightCD16- NK cells from all tissue sites (top) and
scatterplots showing log normalized counts of key tissue-residence genes shown in Figure 5B heatmap (bottom). Dots show data for each individual sample and
the line connects the mean value for each group of samples.
(B) Scatterplots showing the frequency of CD69+CD56brightCD16- NK cells in each tissue site as a function of age and line of best fit between the variables,
pearsonr indicates the Pearson correlation coefficient for the comparison.
(C) Heterogeneity of trNK cells. SPADE plots for NK cells isolated from blood, BM, spleen, lung, gut, LLN, and MLN (donor 1) and from blood, BM, spleen, lung,
and LLN for 3 additional donors (donors 2, 3, and 4). Solid black arrow identifies CD103+ CD49+ NK cells and dashed black arrow identifies CXCR6+ NK cells. BM,
bone marrow; LLN, lung draining LN; MLN, mesenteric LN
(legend on next page)
Figure S6. Gating Strategy and Representative Flow Plots for Clusters Identified by High-Dimensional Flow Cytometry Analysis, Related to
Figure 7
(A) NK cells were identified as SSC-AlowCD45+CD1419-CD3-CD56+ cells and used to carry out further analysis as described in materials and methods.
(B) Representative flow plots showing the expression ofmarkers on NK cell clusters identified by high-dimensional analysis. BM, bonemarrow; LLN, lung draining
LN; MLN, mesenteric LN.
Figure S7. CD56brightCD16 NK Cells in Tissues Are Phenotypically and Transcriptionally Distinct from Known ILC Subsets, Related to
Figure 7
(A) Representative histograms showing the expression of RORgt on CD127+ andCD127- cells in blood and tissue sites on top, and on bottom boxplot showing the
frequency of CD127+RORgt+ cells of the total CD3-CD56+ cells in blood and tissue sites compiled from 5-13 donors.
(B) PCA plot showing comparison of the transcription profile of NK cells from spleen (golden squares) and LLN (cyan triangles) from this study and NK cells and
ILC subsets from spleen and jejunum from the ILC study (Yudanin et al., 2019). BM, bone marrow; LLN, lung draining LN; MLN, mesenteric LN.
